The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback